Skip to main content

Combined immunohistochemistry for thyroid peroxidase, galectin‐3, CK19 and HBME‐1 in differential diagnosis of thyroid tumors

Buy Article:

$48.00 plus tax (Refund Policy)

Abstract:

Paunovic I, Isic T, Havelka M, Tatic S, Cvejic D, Savin S. Combined immunohistochemistry for thyroid peroxidase, galectin‐3, CK19 and HBME‐1 in differential diagnosis of thyroid tumors. APMIS 2012; 120: 368–79.

We evaluated some proposed molecular thyroid tumor markers: thyroid peroxidase (TPO), galectin‐3, cytokeratin‐19, and HBME‐1, individually and in combination, by immunohistochemistry in a total of 242 archival thyroid tissue sections. The expression of each individual marker was most helpful for the diagnosis of papillary carcinoma and its follicular variant. However, none of them was sensitive and specific enough to discriminate between Hürthle adenoma and carcinoma. Galectin‐3 and HBME‐1 could be used as single discriminators between follicular thyroid adenoma and carcinoma, but HBME‐1 is the better choice. As a single test, all analyzed tumor markers had sufficient power to predict differentiated thyroid cancer, with sensitivities ranging from 66.5% to 82.2%. The sensitivity was improved by using combinations of some proposed markers. Only two antigens, HBME‐1 and TPO, had distinct predictive values for different diagnostic alternatives i.e. a sequential combination improved diagnostic accuracy between follicular thyroid adenoma and the follicular variant of papillary thyroid carcinoma to 92.6% and consequently, between overall benign and malignant thyroid tumors to 89.1%. HBME‐1 is the most accurate ancillary stain in discriminating well‐differentiated thyroid carcinomas from benign tumors, although the addition of TPO did improve accuracy and served as a useful confirmatory marker.

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2011.02842.x

Affiliations: 1: Center for Endocrine Surgery, Institute of Endocrinology, Diabetes and Diseases of Metabolism, Clinical Center of Serbia, University of Belgrade, Belgrade 2: Institute for the Application of Nuclear Energy – INEP, University of Belgrade, Zemun-Belgrade 3: Institute of Pathology, Medical Faculty, University of Belgrade, Belgrade, Serbia

Publication date: May 1, 2012

mksg/apm/2012/00000120/00000005/art00003
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more